Gemue puts automation inside
Pneumatic aseptic valves offer reduced installation costs and minimise faults
In the past, users needed three products to establish a functional unit – a valve, a solenoid and a switchbox, which had to be assembled using valve-specific mounting kits. Valve, measurement and control system company Gemue says the 651 provides a complete solution. It requires little mechanical installation and is ready for operation within just a few minutes thanks to the SpeedAP function. An analogue travel sensor continuously detects the valve position and the data is evaluated via a microprocessor.
The Gemue 651 is available as an open/close valve or with integrated positioner as a control valve in the nominal sizes DN 4–25. The maximum permissible operating pressure is 10 bar with EPDM diaphragms and 6 bar with PTFE diaphragms. The maximum permissible operating temperature during sterilisation is 150°C. The valve is CIP/SIP capable. Its compact design makes it ideally suitable for use where space is at a premium, for example within valve batteries and as a component of valve blocks in multi-port design. The pneumatic actuator section of the housing is made from stainless steel, while the automation module located above is made from PP (polypropylene).
Gemue says the essential advantages for the customer are: lower price; reduced installation costs; and reduced operating costs.
The valve is GMP-compatible, minimises potential faults such as leakages, connection and mounting errors as a result of integration and offers simplified logistics and materials management because there is now only one article number for the complete valve.
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
Upcoming event
You may also like
Manufacturing
Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies
Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
Manufacturing
Vetter Pharma to build new manufacturing site in Germany as part of €1.5bn global expansion plan
The company has submitted a building permit application for a new commercial manufacturing facility in Saarland, Germany, with construction set to begin in Q2 2026 and operations planned for 2031